Commodore Capital LP - 10%+ Owner at Ambrx Biopharma Cayman, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
AMAM
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Commodore Capital LP since 13 Sep 2025

Reported holdings for Commodore Capital LP in Ambrx Biopharma Cayman, Inc.

Form 4 holding 10%+ Owner

Ambrx Biopharma Inc.

Security class
Ordinary Shares
Shares / value
35,700,000
Estimated value
$330,035,790
Report date
23 Feb 2023
Price
$9.24
Ownership
By Commodore Capital Master LP

Transaction history for Commodore Capital LP in Ambrx Biopharma Cayman, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .